Now showing items 81-90 of 197
TrueNTH Sexual Recovery Intervention for couples coping with prostate cancer: Randomized controlled trial results
(Harrington PressWiley Periodicals, Inc., 2022-04-01)
Application of the Milan System for Reporting Salivary Gland Cytopathology in pediatric patients: An international, multi-institutional study
(Churchill LivingstoneWiley Periodicals, Inc., 2022-05)
Gene therapy: Practical aspects of implementation
(Wiley Periodicals, Inc., 2022-05)
The first wave of gene therapies for haemophilia submitted for regulatory review utilize a liver-directed approach in which a functional gene copy of factor VIII (FVIII) or factor IX (FIX) is packaged inside a recombinant ...
Outcomes of long-term von Willebrand factor prophylaxis use in von Willebrand disease: A systematic literature review
(Wiley Periodicals, Inc., 2022-05)
BackgroundVon Willebrand Disease (VWD) is a common inherited bleeding disorder. Patients with VWD suffering from severe bleeding may benefit from the use of secondary long-term prophylaxis.AimSystematically summarize the ...
Health issues in women and girls affected by haemophilia with a focus on nomenclature, heavy menstrual bleeding, and musculoskeletal issues
(Wiley Periodicals, Inc.All About Hemophilia, 2022-05)
IntroductionWomen and girls affected by haemophilia, including haemophilia carriers (WGH) are at risk of bleeding symptoms that may go unrecognized, including heavy menstrual bleeding (HMB) and musculoskeletal bleeding. ...
Evaluating the association of frailty with communication about aging‐related concerns between older patients with advanced cancer and their oncologists
(Wiley Periodicals, Inc.National Cancer Institute, 2022-03-01)
Perceived financial decline related to breast reconstruction following mastectomy in a diverse population‐based cohort
(John Wiley & Sons, 2022-03-15)
Gilteritinib clinical activity in relapsed/refractory FLT3 mutated acute myeloid leukemia previously treated with FLT3 inhibitors
(John Wiley & Sons, Inc., 2022-03-01)
Gilteritinib is approved for the treatment of relapsed/refractory (R/R) acute myeloid leukemia (AML) with an FLT3- mutation (FLT3mut+). However, the gilteritinib phase 3 ADMIRAL study (Perl et al NEJM 2019) was conducted ...
Association of pulse pressure, pulse pressure index, and ambulatory arterial stiffness index with kidney function in a cross‐sectional pediatric chronic kidney disease cohort from the CKiD study
(Wiley Periodicals, Inc., 2020-06)
The morbidity and mortality of adult and pediatric chronic kidney disease (CKD) and end‐stage renal disease (ESRD) populations are mainly driven by cardiovascular disease (CVD). Improving CVD outcomes focuses on risk ...